{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:23:13Z","timestamp":1759332193528},"reference-count":22,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T00:00:00Z","timestamp":1294963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Exper Ophthalmology"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>A<jats:sc>bstract<\/jats:sc><\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> To compare aqueous humour and plasma levels of ghrelin, a peptide recently identified in human eyes, in patients with open\u2010angle glaucoma and controls.<\/jats:p><jats:p><jats:bold>Design:\u2002<\/jats:bold> Cross\u2010sectional, controlled, hospital\u2010based study.<\/jats:p><jats:p><jats:bold>Participants:\u2002<\/jats:bold> Twenty\u2010four open\u2010angle glaucoma (17 primary open\u2010angle and 7 pseudo\u2010exfoliation glaucoma) patients and 30 controls were included. All participants were patients scheduled for cataract or glaucoma surgery. Patients with other ocular pathology, previous ocular surgery or diabetes were excluded.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Blood samples were collected before elective surgery. Aqueous humour was aspirated from the anterior chamber through a paracentesis with a 27\u2010G needle under sterile conditions before any tissue manipulation. Ghrelin quantification was performed with commercially available Radioimmunoassay kits.<\/jats:p><jats:p><jats:bold>Main Outcome Measure:\u2002<\/jats:bold> Ghrelin levels in aqueous humour and plasma.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Plasma levels of ghrelin were 490.5\u2003\u00b1\u2003156.0\u2003pg\/mL in the open\u2010angle glaucoma and 482.2\u2003\u00b1\u2003125.4\u2003pg\/mL in the control group (Mann\u2013Whitney test, <jats:italic>P<\/jats:italic>\u2003=\u20030.897). Aqueous humour levels of ghrelin were 85.5\u2003\u00b1\u200315.4 and 123.4\u2003\u00b1\u200325.5\u2003pg\/mL in the respective groups (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). The ratio of plasma\/aqueous humour ghrelin concentration was higher in the open\u2010angle glaucoma <jats:italic>versus<\/jats:italic> the control group (5.75\u2003\u00b1\u20031.92 <jats:italic>vs.<\/jats:italic> 4.00\u2003\u00b1\u20031.04, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). There was no difference in aqueous humour levels of ghrelin between primary open\u2010angle glaucoma and pseudo\u2010exfoliation glaucoma patients (<jats:italic>P<\/jats:italic>\u2003=\u20030.494).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Aqueous humour levels of ghrelin were significantly lower in open\u2010angle glaucoma patients, compared with controls. This difference may manifest a role of ghrelin in the disease process or a consequence of antiglaucoma treatment.<\/jats:p>","DOI":"10.1111\/j.1442-9071.2010.02463.x","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T13:15:12Z","timestamp":1289481312000},"page":"324-329","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plasma and aqueous humour levels of ghrelin in open\u2010angle glaucoma patients"],"prefix":"10.1111","volume":"39","author":[{"given":"Andreas","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Dastiridou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierros","family":"Cholevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kotoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia E","family":"Tsironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,14]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/45230"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.6.8739"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2006.06.005"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031964"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200207165"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)02083-1"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.09.001"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2004.03.002"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.1.06187"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.041237"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nn1656"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2005.01340.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.10.2546"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890601149179"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.10.7885"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704815"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0083-6729(06)77009-1"},{"key":"e_1_2_5_19_2","volume-title":"Terminology and Guidelines for Glaucoma","author":"European Glaucoma Society","year":"2008"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.134627"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2407"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2007.08.027"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713680701791058"}],"container-title":["Clinical &amp; Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-9071.2010.02463.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1442-9071.2010.02463.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T15:24:58Z","timestamp":1697383498000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1442-9071.2010.02463.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1442-9071.2010.02463.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02463.x","archive":["Portico"],"relation":{},"ISSN":["1442-6404","1442-9071"],"issn-type":[{"value":"1442-6404","type":"print"},{"value":"1442-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,14]]},"assertion":[{"value":"2011-01-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}